<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00764530</url>
  </required_header>
  <id_info>
    <org_study_id>Study 100</org_study_id>
    <nct_id>NCT00764530</nct_id>
  </id_info>
  <brief_title>Cementless Alumina-Alumina Total Hip and Hybrid</brief_title>
  <official_title>Keramos Ceramic/Ceramic Total Hip System</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Encore Medical, L.P.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Encore Medical, L.P.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluate the safety and efficacy of the CeramTec Acetabular Alumina Insert and CeramTec&#xD;
      Alumina head when used with the Foundation Porous Coated Acetabular Shell and an Encore hip&#xD;
      stem.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2003</start_date>
  <completion_date type="Actual">January 2015</completion_date>
  <primary_completion_date type="Actual">January 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Alumina/Alumina articulation will perform as well as the alumina/polyethylene.</measure>
    <time_frame>5 year</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">342</enrollment>
  <condition>Rheumatoid Arthritis</condition>
  <condition>Osteoarthritis</condition>
  <condition>Post-traumatic Arthritis</condition>
  <condition>Avascular Necrosis</condition>
  <arm_group>
    <arm_group_label>Investigational</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>CeramTec Acetabular Alumina Insert and CeramTec Alumina head used with Foundation Porous Coated Acetabular Shell.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Device</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Foundation Porous Coated Acetabular Shell with Polyethylene Insert with the CeramTec Alumina head.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Alumina/Alumina</intervention_name>
    <description>CeramTec Acetabular Alumina Insert and CeramTec Alumina head used with Foundation Porous Coated Acetabular Shell</description>
    <arm_group_label>Investigational</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Standard</intervention_name>
    <description>Foundation Porous Coated Acetabular Shell with Polyethylene Insert with the CeramTec Alumina head</description>
    <arm_group_label>Control Device</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients with inflammatory tissue disorders (e.g. rheumatoid arthritis, lupus, etc),&#xD;
             osteoarthritis, post-traumatic arthritis or secondary arthritis, or avascular&#xD;
             necrosis.&#xD;
&#xD;
          -  Less than 70 on preoperative HHS score&#xD;
&#xD;
          -  Primary total hip replacement&#xD;
&#xD;
          -  Patient is likely to be available for evaluation for the duration of the study.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with physical conditions that would eliminate adequate implant support or&#xD;
             prevent the use of an appropriately sized implant (e.g., tumor)&#xD;
&#xD;
          -  Previous surgery that has adversely affected bone stock (such as some hip pinning or&#xD;
             some osteotomies) or prior total hip replacement.&#xD;
&#xD;
          -  Insufficient quality or quantity of bone resulting from conditions such as:&#xD;
&#xD;
               -  Cancer, where radiation has destroyed the available bonestock&#xD;
&#xD;
               -  Congenital dislocation&#xD;
&#xD;
               -  Metabolic bone disease of the upper femur or pelvis&#xD;
&#xD;
               -  Femoral osteotomy revision&#xD;
&#xD;
               -  Girdlestone revision&#xD;
&#xD;
               -  Active infection of the hip joint&#xD;
&#xD;
               -  Old or remote infection&#xD;
&#xD;
               -  Other conditions that lead to inadequate skeletal fixation&#xD;
&#xD;
          -  Neurological conditions that might hinder patient's ability to follow study&#xD;
             procedures, e.g., to restrict physical activities (e.g., Severe Parkinson's, CVA on&#xD;
             affected side)&#xD;
&#xD;
          -  Patient's mental condition that may interfere with his ability to give an informed&#xD;
             consent or willingness to fulfill the required follow-up of the study&#xD;
&#xD;
               -  Mental illness&#xD;
&#xD;
               -  Senility&#xD;
&#xD;
               -  Drug Abuse&#xD;
&#xD;
               -  Alcoholism&#xD;
&#xD;
          -  Conditions that place excessive demands on the implant&#xD;
&#xD;
               -  Charcot's joints&#xD;
&#xD;
               -  Muscle deficiencies&#xD;
&#xD;
               -  Multiple joint disabilities&#xD;
&#xD;
               -  Refusal to modify postoperative physical activities&#xD;
&#xD;
               -  Skeletal immaturity&#xD;
&#xD;
               -  Obesity (50% over recorded body weight mass index)&#xD;
&#xD;
          -  Greater than or equal to 70 on preoperative HHS score&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Mark Newman, Inc.</name>
      <address>
        <city>Newport Beach</city>
        <state>California</state>
        <zip>92663</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Charleston Orthopaedic Assoc.</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29414</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Advanced Orthopaedic Centers</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23294</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.djosurgical.com</url>
    <description>Sponsor company home page</description>
  </link>
  <verification_date>July 2017</verification_date>
  <study_first_submitted>September 30, 2008</study_first_submitted>
  <study_first_submitted_qc>October 1, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 2, 2008</study_first_posted>
  <last_update_submitted>July 26, 2017</last_update_submitted>
  <last_update_submitted_qc>July 26, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 28, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthritis</mesh_term>
    <mesh_term>Necrosis</mesh_term>
  </condition_browse>
  <pending_results>
    <submitted>March 8, 2021</submitted>
    <returned>March 31, 2021</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

